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ABSTRACT 
 
 
Background: Alzheimer’s disease (AD) is the most common cause of dementia. There 
are about 50,000 people in Malaysia who suffer from the disease and most of them are 
not diagnosed. Pharmacists are a part of the healthcare team, however the depth of their 
knowledge in managing AD is unknown and some of them handle AD patients without 
specializing in neurology and geriatry. This study is to assess the level of AD knowledge 
among pharmacists in health clinics and hospitals and to identify the relationship 
between demographic characteristics and the knowledge of AD. 
Method: Questionnaire consisting of demographic backgrounds and a validated 30 
items- Alzheimer disease knowledge scale (ADKS) tool was used to assess AD 
knowledge. There were 7 health clinics and 9 hospitals recruited by convenience 
sampling and manual surveys were distributed to nearby healthcare clinics and 
hospitals. For the pharmacists working in distant areas, email was used to distribute the 
questionnaires. The score was compared and evaluated across demographics categories. 
Results: 445 pharmacists were obtained with diverse demographic background, the 
overall total mean score was 18.76(3.62): for healthcare professionals the mean score 
was 19.05(3.69) and for hospitals it was 18.47(3.56).Generally the level of AD 
knowledge was moderate and there was no difference in AD knowledge between 
pharmacists in health clinics and hospitals (p= 0.095). For the individual ADKS 
domain, there was significant result shown in care giving (p=0.033) where hospital 
pharmacists possessed higher scores than health clinics, domains of symptoms and 
course of disease were shown to have the lowest score. These two domains are more 
medical-oriented, whilst treatment and care giving had the highest score. TPN and 
Outpatients unit had the highest score. However the TPN sample was too small so it 
may not represent the real population of the TPN unit. Clinical pharmacists which have 
direct contact with patients had lower scores than outpatient pharmacists and this 
suggests that AD patients are usually treated as outpatients. Three independent 
predictors were found in this study: Malays ethnicity, aged less than 30 and outpatients’ 
pharmacists. These three independent variables gave positive relationship to AD score.  
Conclusion: Majority AD knowledge among pharmacists in Selangor was at a 
moderate level. Malay, outpatient pharmacists and those respondents aged less than 30 
scored the highest. Limitations in this study were the background on training and 
experience on AD should be incorporated so that the findings can be more accurate in 
evaluating the AD knowledge individually. This study suggests and supports the 
suggestion for ongoing education and training programme on AD for pharmacists in 
various disciplines.  
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